logo
Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine
Bilateral cardiac sympathetic denervation: why, who and when?
Study suggestive of higher cardiovascular risk in women on high-protein, low-carbohydrate diets
Subclavian transcatheter aortic valve implantation may be a safe, feasible alternative to transfemoral access
Earlier rather than later? Study finds vasomotor symptoms early in menopause may not be linked to increased cardiovascular risk markers
Study may have found the master regulator of cardiac stem cells
Calorie restriction may keep the heart young
Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study
Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial
Long-term clinical experience with zofenopril
Innovation in the diagnosis and treatment of cardiac arrhythmias
Circulating endothelial cells, plaque rupture and acute coronary syndromes
Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges
Pulmonary vein isolation with a novel endoscopic ablation system using laser energy
Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y12 receptor inhibitors
New cell therapies in cardiology
Biomaterial applications in cardiovascular tissue repair and regeneration
Coronary heart disease in Type 2 diabetes: mechanisms and comprehensive prevention strategies
Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan
Acknowledgements